Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mayumi Nakagawa

Concepts (235)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
173
4.490
 Why?
Human papillomavirus 16
11
2021
44
3.550
 Why?
Uterine Cervical Neoplasms
10
2024
299
3.270
 Why?
Papillomavirus Vaccines
7
2021
70
3.220
 Why?
Oncogene Proteins, Viral
11
2011
54
2.410
 Why?
Papillomaviridae
7
2019
105
2.290
 Why?
Repressor Proteins
9
2011
155
2.070
 Why?
Epitopes, T-Lymphocyte
7
2018
26
1.870
 Why?
Cancer Vaccines
3
2021
78
1.580
 Why?
T-Lymphocytes
6
2021
340
1.400
 Why?
Candida
4
2018
63
1.310
 Why?
CD8-Positive T-Lymphocytes
6
2018
132
1.280
 Why?
Cervix Uteri
3
2021
49
0.860
 Why?
Uterine Cervical Dysplasia
2
2015
51
0.820
 Why?
Immunity, Cellular
4
2013
64
0.720
 Why?
Lymphocytes, Tumor-Infiltrating
1
2021
78
0.710
 Why?
Epitopes
2
2015
65
0.690
 Why?
Langerhans Cells
3
2018
11
0.690
 Why?
Neoplasms
2
2021
1325
0.650
 Why?
Viral Load
2
2019
82
0.650
 Why?
Health Education
1
2021
156
0.640
 Why?
Cell Cycle Checkpoints
1
2019
32
0.630
 Why?
HLA Antigens
4
2006
56
0.600
 Why?
Humans
43
2025
52483
0.570
 Why?
Adult
21
2025
14161
0.560
 Why?
CD4-Positive T-Lymphocytes
3
2018
164
0.560
 Why?
Colorectal Neoplasms
1
2021
294
0.560
 Why?
Female
29
2025
28171
0.540
 Why?
Health Knowledge, Attitudes, Practice
1
2021
509
0.520
 Why?
Plasma Exchange
2
2014
25
0.500
 Why?
Cross Protection
1
2015
4
0.480
 Why?
T-Lymphocytes, Regulatory
2
2016
84
0.480
 Why?
Colposcopy
1
2015
17
0.470
 Why?
Interleukin-12
2
2018
27
0.470
 Why?
Adjuvants, Immunologic
2
2018
52
0.460
 Why?
Immunity, Innate
1
2015
117
0.440
 Why?
Interferon-gamma
2
2012
180
0.430
 Why?
Health
1
2013
21
0.430
 Why?
Lectins, C-Type
1
2013
31
0.430
 Why?
Papillomavirus E7 Proteins
8
2018
32
0.430
 Why?
Middle Aged
15
2025
13028
0.420
 Why?
Patient Selection
1
2015
259
0.420
 Why?
Young Adult
9
2021
4329
0.410
 Why?
Afibrinogenemia
1
2012
5
0.400
 Why?
Enzyme-Linked Immunospot Assay
1
2012
3
0.390
 Why?
T-Lymphocytes, Cytotoxic
4
2009
66
0.390
 Why?
Breast Neoplasms
1
2021
1212
0.380
 Why?
Cell Proliferation
5
2021
1023
0.360
 Why?
Vaginal Smears
3
2021
28
0.360
 Why?
Warts
1
2010
13
0.350
 Why?
Plateletpheresis
1
2010
7
0.350
 Why?
Antigens, Fungal
1
2010
20
0.350
 Why?
Blood Preservation
1
2010
27
0.350
 Why?
Early Detection of Cancer
3
2021
189
0.350
 Why?
Dermatitis
1
2010
36
0.340
 Why?
Blood Proteins
1
2010
85
0.340
 Why?
Anaphylaxis
1
2010
69
0.330
 Why?
Cells, Cultured
5
2021
1567
0.320
 Why?
Antigens, Viral
2
2009
43
0.300
 Why?
Immunotherapy
1
2010
244
0.300
 Why?
Human papillomavirus 18
1
2008
9
0.300
 Why?
Telemedicine
1
2015
494
0.300
 Why?
Blood Platelets
1
2010
259
0.290
 Why?
Host-Pathogen Interactions
2
2021
144
0.280
 Why?
Vaccinia virus
1
2007
6
0.270
 Why?
Dendritic Cells
1
2008
136
0.270
 Why?
Hematopoietic Stem Cell Transplantation
2
2025
603
0.270
 Why?
Immunoenzyme Techniques
1
2007
137
0.270
 Why?
Immunophenotyping
1
2007
117
0.260
 Why?
Neoplasm Staging
2
2025
772
0.260
 Why?
Aged
10
2025
10121
0.240
 Why?
Blood Component Removal
1
2025
15
0.240
 Why?
Isoantibodies
1
2004
30
0.230
 Why?
Cell Line, Tumor
5
2021
1470
0.230
 Why?
Neoplasm Grading
2
2021
126
0.230
 Why?
Lead
1
2004
33
0.230
 Why?
Infant, Very Low Birth Weight
1
2004
48
0.220
 Why?
Neutropenia
1
2004
115
0.220
 Why?
Endometrial Neoplasms
1
2025
144
0.220
 Why?
Oropharyngeal Neoplasms
1
2024
19
0.220
 Why?
DNA, Viral
3
2011
137
0.220
 Why?
Anus Neoplasms
1
2024
25
0.210
 Why?
Hematopoietic Stem Cells
1
2025
187
0.210
 Why?
Blood Transfusion
1
2004
127
0.210
 Why?
Coinfection
1
2024
47
0.210
 Why?
Penile Neoplasms
1
2024
44
0.210
 Why?
High-Throughput Nucleotide Sequencing
2
2021
182
0.200
 Why?
Adolescent
5
2021
6739
0.200
 Why?
Antibody Formation
1
2002
51
0.200
 Why?
Capsid Proteins
1
2002
24
0.200
 Why?
Practice Guidelines as Topic
1
2025
488
0.190
 Why?
Genes, T-Cell Receptor
1
2021
5
0.190
 Why?
Clone Cells
3
2007
77
0.190
 Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.190
 Why?
Treatment Outcome
3
2021
5422
0.190
 Why?
Cytokines
2
2016
623
0.190
 Why?
Pilot Projects
2
2021
721
0.180
 Why?
Remission Induction
1
2021
218
0.180
 Why?
Mass Screening
2
2021
357
0.180
 Why?
Lymphocyte Activation
1
2021
172
0.180
 Why?
Cystadenocarcinoma, Serous
1
2021
73
0.180
 Why?
Videotape Recording
1
2021
27
0.180
 Why?
Left-Right Determination Factors
1
2020
1
0.180
 Why?
Nodal Protein
1
2020
3
0.180
 Why?
Amino Acid Sequence
3
2008
578
0.170
 Why?
Mammography
1
2021
99
0.170
 Why?
Focus Groups
1
2021
196
0.170
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
235
0.160
 Why?
Multiple Myeloma
2
2025
3049
0.160
 Why?
Metagenome
1
2019
40
0.160
 Why?
Male
10
2024
26761
0.160
 Why?
Glioblastoma
1
2020
97
0.160
 Why?
Dose-Response Relationship, Drug
2
2016
1378
0.160
 Why?
Parenteral Nutrition
1
2019
27
0.150
 Why?
Feasibility Studies
1
2021
406
0.150
 Why?
Up-Regulation
1
2020
454
0.150
 Why?
Health Behavior
1
2021
257
0.150
 Why?
Transplantation Conditioning
1
2019
93
0.150
 Why?
DNA
1
2021
549
0.150
 Why?
Time Factors
2
2021
2968
0.140
 Why?
Leukocytes, Mononuclear
2
2016
123
0.140
 Why?
Bacteria
1
2019
228
0.140
 Why?
HLA-B Antigens
2
2008
8
0.140
 Why?
Cell Line
2
2012
1030
0.140
 Why?
Age Factors
1
2021
1132
0.140
 Why?
Ovarian Neoplasms
1
2021
459
0.130
 Why?
Brain Neoplasms
1
2020
291
0.130
 Why?
Histocompatibility Antigens Class II
2
2008
36
0.130
 Why?
Retrospective Studies
5
2025
6607
0.130
 Why?
Vaccines, Subunit
1
2016
15
0.130
 Why?
Head and Neck Neoplasms
1
2019
288
0.130
 Why?
Body Mass Index
1
2019
689
0.120
 Why?
Molecular Sequence Data
2
2008
778
0.120
 Why?
Adaptive Immunity
1
2015
34
0.120
 Why?
Chromatography, Liquid
1
2016
240
0.120
 Why?
Leukocyte Count
2
2004
73
0.120
 Why?
Peptides
2
2006
223
0.110
 Why?
Factor VIII
1
2014
23
0.110
 Why?
Tandem Mass Spectrometry
1
2016
251
0.110
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
14
0.110
 Why?
ADAM Proteins
1
2014
20
0.110
 Why?
Proteome
1
2016
171
0.110
 Why?
Antigens, CD1
1
2013
9
0.110
 Why?
Mannose-Binding Lectins
1
2013
8
0.110
 Why?
Receptors, Pattern Recognition
1
2013
4
0.110
 Why?
Indicators and Reagents
1
2013
36
0.110
 Why?
Intracellular Space
1
2013
26
0.110
 Why?
Skin Tests
1
2013
58
0.110
 Why?
Vaccination
1
2016
298
0.110
 Why?
Cadherins
1
2013
62
0.110
 Why?
Proteomics
1
2016
329
0.100
 Why?
Communication
1
2015
257
0.100
 Why?
Rural Health Services
1
2015
170
0.100
 Why?
Research Design
1
2015
359
0.100
 Why?
Antigens, CD
1
2013
218
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
582
0.100
 Why?
Socioeconomic Factors
1
2015
610
0.100
 Why?
Longitudinal Studies
2
2005
747
0.090
 Why?
Injections, Intralesional
1
2010
31
0.090
 Why?
Isotonic Solutions
1
2010
20
0.090
 Why?
Platelet Transfusion
1
2010
33
0.090
 Why?
P-Selectin
1
2010
30
0.090
 Why?
Sodium Chloride
1
2010
56
0.090
 Why?
Platelet Aggregation
1
2010
72
0.090
 Why?
Platelet Activation
1
2010
47
0.080
 Why?
Hypersensitivity
1
2010
81
0.080
 Why?
Japan
2
2025
38
0.080
 Why?
Complement Factor I
1
2008
2
0.080
 Why?
Polymerase Chain Reaction
1
2010
461
0.080
 Why?
HLA-A Antigens
1
2008
11
0.070
 Why?
Haplotypes
1
2008
92
0.070
 Why?
Antigen Presentation
1
2008
26
0.070
 Why?
Immunologic Memory
1
2008
31
0.070
 Why?
Histocompatibility Antigens Class I
1
2008
48
0.070
 Why?
Prognosis
2
2025
2099
0.070
 Why?
Signal Transduction
2
2020
1671
0.070
 Why?
DNA, Recombinant
1
2007
15
0.070
 Why?
Genes, MHC Class I
1
2006
11
0.070
 Why?
Animals
2
2019
13505
0.070
 Why?
Binding, Competitive
1
2006
90
0.070
 Why?
Arkansas
1
2013
2028
0.070
 Why?
Polymorphism, Single Nucleotide
1
2008
505
0.060
 Why?
Leukapheresis
1
2025
19
0.060
 Why?
Antigens, CD34
1
2025
72
0.060
 Why?
Calgranulin B
1
2005
4
0.060
 Why?
Calgranulin A
1
2005
5
0.060
 Why?
Cryopreservation
1
2025
41
0.060
 Why?
Immunomagnetic Separation
1
2004
7
0.060
 Why?
Epitope Mapping
1
2004
7
0.060
 Why?
Societies, Medical
1
2025
200
0.060
 Why?
Risk Factors
1
2013
3889
0.050
 Why?
Transplantation, Autologous
1
2025
488
0.050
 Why?
Phosphorylation
2
2020
528
0.050
 Why?
Sensitivity and Specificity
1
2005
891
0.050
 Why?
Mutation
1
2008
1347
0.050
 Why?
Tumor Virus Infections
1
2002
48
0.050
 Why?
Antibodies, Viral
1
2002
109
0.050
 Why?
Lactobacillus
1
2021
4
0.050
 Why?
SOX Transcription Factors
1
2021
4
0.050
 Why?
Immunoglobulin G
1
2002
195
0.050
 Why?
Neuroendocrine Cells
1
2021
10
0.050
 Why?
Biological Specimen Banks
1
2021
22
0.050
 Why?
Cytodiagnosis
1
2021
43
0.050
 Why?
Neoplasm Recurrence, Local
1
2025
649
0.040
 Why?
Cytoplasm
1
2021
94
0.040
 Why?
Cobalt
1
2020
17
0.040
 Why?
Recurrence
1
2002
672
0.040
 Why?
Cell Hypoxia
1
2020
83
0.040
 Why?
Vulnerable Populations
1
2020
52
0.040
 Why?
Neoplastic Stem Cells
1
2021
99
0.040
 Why?
Cohort Studies
1
2004
1542
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
57
0.040
 Why?
Cell Movement
1
2021
268
0.040
 Why?
Community Health Workers
1
2020
50
0.040
 Why?
Multivariate Analysis
1
2021
591
0.040
 Why?
Parenteral Nutrition, Total
1
2019
29
0.040
 Why?
Sequence Analysis, DNA
1
2019
229
0.040
 Why?
Cell Survival
1
2020
612
0.040
 Why?
Cell Differentiation
1
2021
665
0.040
 Why?
Phenotype
1
2021
789
0.040
 Why?
Linear Models
1
2019
287
0.040
 Why?
Models, Biological
1
2021
735
0.040
 Why?
Immunity, Humoral
1
2018
23
0.040
 Why?
Aged, 80 and over
1
2025
3392
0.040
 Why?
Infant, Newborn
1
2004
2867
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2020
857
0.030
 Why?
Autoantibodies
1
2014
121
0.030
 Why?
Immunosuppressive Agents
1
2014
243
0.020
 Why?
Mice, Inbred C57BL
1
2018
1884
0.020
 Why?
Combined Modality Therapy
1
2014
639
0.020
 Why?
Genetics, Population
1
2008
13
0.020
 Why?
Alleles
1
2008
276
0.020
 Why?
Mice
1
2018
5949
0.020
 Why?
Casein Kinase II
1
2005
10
0.010
 Why?
Cell Division
1
2005
291
0.010
 Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (235) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department